10A -The Michigan Daily -Thursday, March 13, 2003
Shaved heads not in the cards for cagers
By Chris Burke
Daily Sports Editor
With no shot at going to the NCAA Tournament,
the Michigan men's basketball team is prepared to
do anything it takes to prolong its run at the Big
Ten Tournament that begins Friday night for the
Well ... almost anything.
"I know I'm not shaving my head," freshman
Daniel Horton said. "My head is shaped kind of
funny - I've got a hump and a dip in my head, so
I'm not shaving mine."
Despite the ever-growing tradition among
NCAA teams to make a team-wide trip to the bar-
bershop just prior to tournament play, the Wolver-
ines haven't made any plans to grace the United
Center court in Chicago with a major fashion
statement reminiscent of the Fab Five.
"We don't really have anything yet," center Gra-
ham Brown said. "I hope they don't bring up any-
thing (like shaving our heads), because I don't
think I'll be dealing with that."
Senior tri-captain Rotolu Adebiyi agreed that
Brown staying away from the whole head-shaving
idea was a smart move on the freshman's part.
"I don't know if I'm too excited about seeing
Graham with a shaved head," Adebiyi said. "I'm
open to whatever - if they want to do something,
that's fine with me. I'd like to keep my hair as long
as I can, but you never know what will happen.
"Overall, we're a team of handsome young men,
and I think we could pull off the look."
While the shaven look has become prominent in
basketball recently, the Michigan hockey team
implemented a variation on the style for last year's
playoffs - the Wolverines opted to keep their hair,
but dye it blonde.
Senior Gavin Groninger said that his high
school team opted to go blonde for its playoffs, but
the rest of the Wolverines would rather keep that
idea on the shelf as well.
"I can't go with the blonde hair," senior LaVell
Blanchard said. "Sorry, I just can't do dyed
The most popular option among team members
appeared to be a Big Ten Tournament title going
hand-in-hand with the shaving of coach Tommy
"We've been talking about that all year," Hor-
ton said. "That if we win the Big Ten Tourna-
ment, we should shave coach Amaker's head, but
I don't know."
It's unclear whether or not Amaker has agreed to a
deal that would leave him bald for a while.
Blanchard claimed that the Wolverines had a chance
to clean Amaker's head, but couldn't finish the job.
"We had an opportunity to do that one, but did-
n't get it done," Blanchard said suspiciously. "I
can't say (why) ... but we didn't get it done."
While the Wolverines don't have any plans as of
now to show camaraderie via baldness as of yet,
that doesn't necessarily mean that something won't
happen before Michigan hits the court to take on
either Indiana or Penn State late tomorrow night.
"You know it's tournament time, so maybe the
night before, in the hotel, guys will start thinking
of stuff," Adebiyi said. "You never know what will
Continued from Page 8A
that you lost those six games. But
his team had bought into his system.
This was clear from day one.
Amaker's ability to motivate his
players looks even more impressive
given what happened at St.
The Bonnies decided not to play
in the final two games of the season
when they found out they couldn't
go to the postseason. Amaker's play-
ers knew the entire season there
would be no promised land, but they
never quit working.
The Wolverines had bought into
Amaker as a person, a leader and a
mentor. The system worked, and
Michigan is now a winning program
again - which is how it will proba-
bly stay for years to come.
Ryan's Badgers had their share of
struggles early in the season too,
and Ryan did a tremendous job of
pulling them out of a hole. But to
compare the situation in Wisconsin
with that in Michigan would be like
comparing night and day. Unlike
Ryan's situation, Amaker's task was
daunting and would have over-
whelmed most people. Plus, with
Wisconsin coming off of a confer-
ence title, the urgency to change
was much stronger in Ann Arbor.
Amaker deserved to be recog-
nized as Coach of the Year for the
about-face he pulled with Michigan
His team's late-season struggles
because it wore down should not
factor into the decision. In the big
picture, he did more for his program
than any other coach did for their
He deserved to be recognized for
his perseverance and faith in his
own methods and his players.
Regardless of wins and losses,
Michigan basketball has changed
for the better.
Naweed Sikora can be reached at
Michigan freshman Graham Brown doesn't think he would look good with a
shaved head, and neither do his teammates.
'M' proving itself before Big Ten Championships
By Gabriola D'Jaen
For the Daily
With only three invitationals left before the Big Ten
Championships arrive, the Michigan women's golf
team is proving to its competition and itself that it is a
realistic threat. After the Wolverines' hopes for improv-
ing their score at the Northrop Grumman Regional
Challenge were dashed due to weather conditions,
coach Kathy Teichert added the California-Irvine
Anteater Invitational to the team's schedule.'
"This was a great experience for us, the timing was
perfect, and it just happened to fall in a perfect spot,"
The two-day tournament, held in Coto de Caza,
Calif., proved to be an opportunity for the women to
shine, and resulted in the Wolverines' second best fin-
ish of the season. When the final 54-holes of golf had
been played, the Wolverines were in third place with a
929 total, following first-place California-Irvine by
four strokes, and a mere two strokes behind Cal State-
Senior Kim Benedict showcased her talent during
this tournament - especially in the second round.
Benedict tied her season-best score with a two-under
par 70. Benedict finished in a tie for fifth place, fol-
lowed by freshman Amy Schmucker, who finished 13th
with 17-over-par for the tournament. Both women
carded their second best total of the season - Bene-
dict with 224, one shot off her season-best, and
Schmucker with 233.
"The more I put myself into a position to finish well
and the more pressure I put on myself to perform, the
better I will be in the future," Benedict said.
The Wolverines usually count on sophomore Laura
Olin to assist Benedict in leading the team. After a
score of 169 after two rounds, Olin was far behind the
lead. She shot a 76 in the final round, but was unable
to repair the damage from her second round of 88.
Olin finished in 29th place with 245 total stokes.
Stephanie Stasik made a notable effort - her 22 over-
par landed her in 21st place - and Courtney Goebel
tied her season-best round with a 77 in the second
The Wolverines have faced disappointment during
final rounds this season. The team struggled during its
last tournament at the Central District Invitational in
Florida, dropping three spots during the last day to tie
for eighth place.
But the Wolverines maintained a level of consistency
throughout this tournament that displayed their
increasing dependability and stability.
"I thought we put ourselves in very good positions to
actually win the tournament," Teichert said. "It was
great to actually have a chance to win it, and I think
that can help our program and our players."
The California-Irvine Invitational was comprised of
13 teams. Among them were two frequent competitors:
Texas Tech, who placed higher than the Wolverines in
the last tournament, and Iowa State.
The Wolverines will confidently head down to
Austin, Texas in less than two weeks for the Betsy
Rawls Invitational over March 24-26. The field will
consist of competitive teams from the Midwest and
South, and should provide a challenging and aggres-
sive atmosphere for the Wolverines.
"The field will be a little more difficult and more
competitive, which is a good thing," Teichert said. "I'm
expecting our players to improve from each tournament
and step up to the challenge."
While improving at each tournament is on Michi-
gan's agenda, there are other motives to attending tour-
naments. As Benedict put it, "It also is just another
opportunity to see grass, which isn't a bad thing from
where we come from."
The Michigan women's golf team had its second best finish of
the season this week at the California-Irvine Invitational.
Continued from Page 8A
Thomson. Though Masters was fine,
there was some chatter in the crowd
about how safe goalies' masks are.
"(The equipment) is definitely setup
to (last)," Montoya said. "But you get
goalies and forwards messing with their
equipment, and they tend to adjust it to
their comfort. They loosen it up, and
maybe that's what happened."
Though a case like Exter's was a rare
event, considering forwards and goalies
go after the same loose puck all the time
- "Usually I lower my shoulder and I
go right after them," Montoya said -
there have been situations where it was-
n't an accident.
"Last year, I was out for a couple
weeks,"Montoya said. "There were a
couple scrums (before the incident), and
fights starting. I guess one guy didn't
really want to fight me (fairly), so they
sent one of their players - two-on-one
- who slid the puck right on through.
The guy in the middle left the puck and
cante after me. My head flipped back,
helmet flipped off, I hit the crossbar and
hit the ice. I had a concussion."
Still, there's not much that can be
done to protect that.
"They don't make goalie masks with
the idea that they're going to be hit by
knees and skates," Michigan coach Red
Berenson said. "You can't protect
As the playoffs approach for the
Wolverines, there is little doubt that
Exter will be on the minds of many.
"It looked like a harmless collision to
tell the truth ... it's just crazy," said
Woodford, after seeing the film. "It
makes you step and look back at how
lucky you are to be playing this game
and to be healthy. Hopefully, he'll get
through it and just have a regular life
-TheAssociatedPress and United States
College Hockey Online contributed to this
L 91 :I:
IEAirtk con~trol you.-tkir-~k a~out jus-t +x a year
medroxyprogesterone acetate injectable suspension
DEPO-PROVERA Contraceptive Injection
(medroxyprogesterone acetate injectable suspension, USP)
This product is intended to prevent pregnancy. It does not protect against HIV
infection (AIDS) and other sexually transmitted diseases.
What is DEPO-PROVERA Contraceptive injection?
DEPO-PROVERA Contraceptive Injection is a form of birth control that is given as an
intramuscular injection (a shot) in the buttock or upper arm once every 3 months (13 weeks). To
continue your contraceptive protection, you must return for your next injection promptly at the
end of 3 months (13 weeks). DEPO-PROVERA contains medroxyprogesterone acetate, a
chemical similar to (but not the same as) the natural hormone progesterone, which is produced
by your ovaries during the second half of your menstrual cycle. DEPO-PROVERA acts by
preventing your egg cells from ripening. If an egg is not released from the ovaries during your
menstrual cycle, it cannot become fertilized by sperm and-result in pregnancy. DEPO-PROVERA
also causes changes in the linrngofyouruterus that make it less likely for pregnancy to occur
How effective is DEPO-PROVERA Contraceptive Injection?
The efficacy of DEPO-PROVERA Contraceptive Injection depends on followin the
recommended dosage schedule exactly (see "How often do I get my shot of DEPO-PR OERA
Contraceptive Injection?"). To make sure you are not pregnant when you first get
DEFPO ROVERA Contraceptive Iejection, your first injection must be given ONLY during
the first 5 days of a normal menstrual period: ONLY within the first 5 days after childbirth if not
breast-feeding and, if exdusively brrast-feeding, ONLY at the sixth week after childbirth. It is a
lort -nrm injectable contractptivc whcn administered at 3-month (13-week) intervals.
DE OPROVERA Contraceptivc 1njecton is over 99% effective, making it one of the most reliable
methods of birth control available. Tis Imans that the average annual pregnancy rate is less than
one for every 10Of women who usc 1liHfO-PROVE PA. The effectiveness of most contraceptive
mneth dss in art on how relably earh woman rses tire method. The effectiveness of
DEPO PROVERA depends only on thc patient returning every 3 months (13 weeks) for her next
injection. Your Iealth-care provider will help you compare DEPO-PROVERA with other
contraceptive mretds and give you the information you need in order to decide which
contraceptive method is the right choice for you.
The following table shows the percent of women who got pregnant while using different kinds of
contraceptive methods. It gives both the lowest expected rate of pregnancy the rate expected
in women who use each method exactly as it should be used) and the typical rate of pregnancy
(which includes women who became pregnant because they forgot to use their birth control or
because they did not follow the directions exactly).
Percent of Women Experiencing an Accidental Pregnancy
in the First Year of Continuous Use
- if you have had cancer of the breast
- if you have had a stroke
" if you have or have had blood clots (phlebitis) in your legs
if you have problems with your liver or liver disease
" if you are allergic to DEPO-PROVERA (medroxyprogesterone acetate or any of its other
What other things should I consider before using DEPO-PROVERA
You will have a physical examination before your doctor prescribes DEO-PROVERA. It is
important to tell your health-care provider if you have any of the following:
" a family history of breast cancer
" an abnormal mammogram (breast x-ray), fibrocystic breast disease, breast nodules or lurips, or
bleeding from your nipples
" kidney disease
- irregular or scanty menstrual periods
" high blood pressure
+ migraine headaches
" epilepsy (convulsions or seizures)
' diabetes or a family history of diabetes
" a history of depression
* if you are taking any prescription or over the-counter medications
This product is intended to prevent pregnancy. It does not protect against
transmission of HIV (AIDS) and other sexually transmitted diseases such as
chiamydia, genital herpes, genital warts, gonorrhea, hepatitis B, and syphilis.
What if I want to become pregnant after using DEPO-PROVERA Contraceptive
Because DEPO-PROVERA is a Iong-acting birth control method, it takes some time after your last
injection for its effect to wear off. Based on the results from a large study done in the United States,
for women who stop using DEPO-PROVERA in order to become pregnant, it is expected that
about half of those who become pregnant will do so in about 10 months after their last injection;
about two thirds of those who become pregnant will do so in about I2 monthy; about 83% of
those who become pregnant will do so in aout 15 months; and about 93% of those who become
pregnant will do so in about I8 months after their last injection. The length of time you use
DEPO-PROVERA has no effect on how lon it takes you to become pregnant after you stop using it.
What are the risks of using DEPO-PROVERA Contraceptive Injection?
I Irregular Menstrual Bleeding
The side effect reported most frequently by women who use DEPO-PROVEA for
contraceotion is a change in their normal menstrual cycle. During the first year of using
DEPO-P OVEPA, you might have one or more of the following changes: irregular or
unpredictable bleeding or spotting, an increase or decrease in menstrual bleeding, or nro bleeding
at all. Unusually heavy or continuous bleeding, however; is not a usual effect of DEPO-PROVERA:
and if this happens, you should see your health-care provider right away With continued use of
DEPO-PROVERA, bleeding usually decreases, and many women stop having periods completely,
In clinical studies of DEPO-PRVERA. 55% of the women studied reported no menstrual
bleeding (amenorrfrea) after I year of use, and 68% of the women studied reported no menstrual
bleeding after 2 years of use. The reason that your periods stop is because DEPO PROVERA
causes a resting state in your ovaries. When your ovaries do riot release an egg monthly, the
regular monthly growth of the lining of your uterus does not occur arid, therefore, the bleeding
that comes with your normal menstruation does not take place. When you stop using
DEPO-PROVERA your menstrual period will usually in time, return to its normal cycle.
2.Bone Mineral Changes
Use of DEPO-PROVERA may be associated with a decrease in the amount of mireral stored in
Women who use hormone-based contraceptives may have an increased risk of blood clots or
stroke. Also, if a contraceptive method fails, there is a possibility that the fertilized egg will begin
to develop outside of the uterus (ectopic pregnancy). While these events are rare, you should
tell your health-care provider if you have any of the problems listed in the next section.
What symptoms may signal problems while using DEPO-PROVERA
Call your health-care provider immediately if any of these problems occur following an injection
" sharp chest pain, coughing up of blood, or sudden shortness of breath (indicating a possible clot
in the lung)
sudden severe headache or vomiting, dizziness or fainting, problems with your eyesight or
speech, weakness, or numbness in an arm or leg (indicating a possible stroke)
. severe pain or swelling in the calf (indicating a possible clot in the leg)
- unusually heavy vaginal bleeding
- severe pain or tenderness in the lower abdominal area
ersistent ain, pus, or bleeding at the injectionsite
Wh~at are the possible side effects of DEPO-PROVERA Contraceptive Injection?
You may experience a weight gain while you are using DEPO-PROVERA. About two thirds of
the women who used DEPO-PROVERA in clinical trials reported a weight gain of about 5 pounds
during the first year of use. You may continue to gain weight after the first year Women in one
large study who used DEPO-PROVERA for 2 years gained an average total of 8,1 pounds over
those 2 years, or approximately 4 pounds per year. Women who continued for 4 years gained an
average total of I 3.8 pounds over those 4 years, or approximately 3.5 pounds per year Women
who continued for 6 years gained an average total of 16.5 pounds over those 6 years, or
approximately 2.75 pounds per year;
2 Onfrr Side Effects
In a clinical study of over 3,900 women who used DEPO-PROVERA for up to 7 years, some
women reported the following effects that may or may not have been related to their use of
DEPO-PROVERA: Irregular menstrual bleeding, amenorrhea, headache, nervousness, abdominal
cramps, dizziness, weakness or fatigue, decreased sexual desire, leg cramps. nausea, vaginal
discharge or irritation, breast swelling and tenderness, bloating, swelling of the hands or feet,
backache, depression, insomnia, acne, pelvic pain, no hair growth or excessive hair loss, rash, hot
flashes, and joint pain. Other problems were reported by very few of the women in the clinical
trials, but some of these could be serious. These include convulsions, jaundice, urinary tract
infections, allergic reactions, fainting, paralysis, osteoporosis, lack of return to fertility, deep vein
thrombosis, pulmonary embolus, breast cancer or cervical cancer If these or any other problems
occur during your use of DEPO-PROVERA, discuss them with your health-care provider
Should any precautions be followed during use of DE PO-PROVERA
During the time you are using DEPO-PROVERA for contraception, you may skip a period, or your
periods may stop completely If you have been receiving your DEPO-PROVERA injections
regularly every 3 months (I3 weeks), then you are probably not pregnant. However, if you think
that you may be pregnant, see your health-care provider.
2Lfborttory Test Interactions
if you are scheduled for any laboratory tests, tell your health-care provider that you are using
D EPO-PROVERA for contraception. Certain blood tests are affected by hormones such as
C yta ren (aminoglutethimide is an anticancer drug that may significantly decrease the
effectiveness of DEPO-PRO ERA if the two drugs are given during the same time.
4.Nursing Mothers -
FOOD FOR THOUGHT
The Iraq protestors that I
have talked to say they feel
that they must do something.
If their protests demanded
that Saddam Hussein suc-
cumb to growing Arab pres-
sure and go into exile, might
he not be forced into it, thus
Gary Lillie & Assoc., Realtors
Killians &Coors Light
9 -10 pm $1.50
Method Expected Typical
1)1Er) P'ROR A ______il 0.
- - ----- --- -
Iemai strilizatal n ii 11 0A4
Maie sien^izat 0 I 0. S
Oril niriia i'rvi (psI) 3
irimbirnei it I
P~yrosnrgen onirly II5